Patents
Patents for C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
08/2014
08/12/2014US8801804 Non-metal tanning process
08/07/2014US20140221650 1 4,2-diazaphospholidine derivatives
07/2014
07/22/2014US8785451 Compounds for the treatment of proliferative disorders
05/2014
05/30/2014WO2014055999A3 Treatment of ocular disorders
05/20/2014US8729114 Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S
02/2014
02/26/2014CN102272261B Phosphorescent emitters
11/2013
11/28/2013DE4428766B4 Benzolderivate und flüssigkristallines Medium Benzene derivatives and liquid crystalline medium
11/07/2013WO2013163892A1 Novel triazolo pyrimidine compounds and a process of preparation thereof
09/2013
09/18/2013CN102395556B Carboxylate compound and use thereof
02/2013
02/12/2013CA2542941C Analysis of mass spectral data in the quiet zones and label selection therefor
12/2012
12/19/2012CN101279952B Method for preparing 1,3-dimethyl alkyleneurea by methylation by step
09/2012
09/18/2012US8268825 Method for the treatment of anthrax infections
09/05/2012CN102653526A 2, 3-diaryl thiazolinone compound and usage thereof in preparation of medicine for treating tumour
07/2012
07/03/2012US8212073 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate
03/2012
03/29/2012DE102010046412A1 Metall-Ligand Koordinationsverbindungen Metal-ligand coordination compounds
12/2011
12/27/2011US8084617 Ionic liquids having fluoroalkyltrifluoroborate anions
12/07/2011CN102272261A 磷光发射体 Phosphorescent emitters
11/2011
11/08/2011US8053454 Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
09/2011
09/29/2011US20110236982 Analysis of mass spectral data in the quiet zones
09/27/2011US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides
09/07/2011EP2362889A1 Phosphorescent emitters
07/2011
07/21/2011WO2010020415A3 Coatings for disease control
05/2011
05/10/2011CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides
02/2011
02/08/2011US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi
01/2011
01/27/2011US20110021482 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
01/13/2011WO2011003342A1 Carboxylate compound and use thereof
05/2010
05/20/2010WO2010056669A1 Phosphorescent emitters
03/2010
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
08/2009
08/27/2009WO2009105604A1 Substituted triazolopyridines
04/2009
04/08/2009CN101402603A Polyhalogenated heterocycle ketene peptide derivative and synthesis thereof
03/2009
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
10/2008
10/08/2008CN101279952A Method for preparing 1,3-dimethyl alkyleneurea by methylation by step
08/2008
08/28/2008US20080207620 Modulators of pharmacokinetic properties of therapeutics
04/2008
04/30/2008EP1916527A1 Analysis of mass spectral data in the quiet zones
02/2008
02/21/2008US20080045536 Fused heterocyclic compounds useful as kinase modulators
10/2007
10/31/2007EP1687638B1 Analysis of mass spectral data in the quiet zones
10/04/2007DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen
09/2007
09/13/2007US20070213538 Ionic Liquids Having Fluoroalkyltrifluoroborate Anions
09/06/2007US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases
07/2007
07/05/2007US20070155748 N-sulfonyl-alpha-amino-acid derivatives
01/2007
01/23/2007US7166724 Ionic liquids
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
12/2006
12/05/2006US7145006 PNA monomer and precursor
11/2006
11/01/2006CN1854206A Process for preparation of alkylimidazolidone (meth)acrylates
10/2006
10/24/2006US7125994 PNA monomer and precursor
10/24/2006US7125993 A2B adenosine receptor antagonists
08/2006
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/09/2006EP1687638A2 Analysis of mass spectral data in the quiet zones
08/02/2006CN1267425C Method for preparing water soluble azo initiator
07/2006
07/26/2006EP0801527B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
07/26/2006CN1266139C Preparation process of alkyl imidazolidone methacrylate
05/2006
05/31/2006EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives
04/2006
04/27/2006WO2005054871A3 Analysis of mass spectral data in the quiet zones
04/04/2006US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
03/2006
03/23/2006DE19547099B4 Verfahren zur Herstellung von (Meth)acrylsäureestern Acrylic acid esters, process for the preparation of (meth)
02/2006
02/01/2006CN1727336A Compound composition prepared in alkylimidazolidone (meth)acrylates solution
01/2006
01/19/2006DE19748440B4 6,7-Difluor-1,2,3,4-tetrahydronaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen, diese enthaltende Flüssigkristallmischungen sowie ferroelektrische Schalt- und/oder Anzeigevorrichtungen 6,7-difluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid crystalline mixtures, liquid crystal mixtures containing them, as well as ferroelectric switching and / or display devices
07/2005
07/14/2005US20050153456 Analysis of mass spectral data in the quiet zones
06/2005
06/16/2005WO2005054871A2 Analysis of mass spectral data in the quiet zones
06/16/2005CA2542941A1 Analysis of mass spectral data in the quiet zones and label selection therefor
05/2005
05/12/2005WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES
03/2005
03/10/2005WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES
12/2004
12/22/2004CN1181077C Ion liquid
11/2004
11/17/2004CN1546475A Method for preparing water soluble azo initiator
08/2004
08/24/2004CA2290252C Process and intermediates for growth hormone secretagogues
02/2004
02/03/2004US6686471 Process and intermediates for growth hormone secretagogues
01/2004
01/28/2004CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives
12/2003
12/04/2003US20030225280 2-Amino-N-(1(R)-benzvloxymethyl-2-(1,3-dioxo-8a(S)-pyridin-2-y lmethyl-2-(2,2,2-trifluoro-ethyl)-hexahydroimidazo(1,5-a)pyraz in-7-yl)-2-oxo- ethyl)-2-methyl-propionamide chloride from piperazine-2-carboxylate esters
09/2003
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
08/2003
08/05/2003US6603002 Process and intermediates for growth hormone secretagogues
05/2003
05/08/2003US20030088097 E.g., tert-butyloxycarbonyl-protected 2-(2,2,2-trifluoroethyl)hexahydroimidazo(1,5-a)pyrazine
01/2003
01/07/2003US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
10/2002
10/15/2002US6465651 Process and intermediates for growth hormone secretagogues
06/2002
06/11/2002US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics
02/2002
02/12/2002CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same
02/07/2002US20020015883 Ionic liquids
01/2002
01/24/2002US20020010335 Process and intermediates for growth hormone secretagogues
12/2001
12/19/2001CN1326936A Ion liquid
12/06/2001DE10026565A1 Ionische Flüssigkeiten Ionic Liquids
12/05/2001EP1160249A2 Ionic liquids
11/2001
11/30/2001CA2348966A1 Ionic liquids
10/2001
10/02/2001US6297380 Process and intermediates for growth hormone secretagogues
09/2001
09/13/2001US20010021388 Cyclization of a triether with a diamine compound
08/2001
08/14/2001CA2162838C Process for preparing an alkylimidazolidone (meth)acrylate
07/2001
07/31/2001US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics
12/2000
12/19/2000US6162425 A keratin-reducing agent without allergic and sensitizing reactions
12/05/2000US6156902 Bis-o-amino (thio) phenols, and their preparation
11/2000
11/21/2000US6150558 Bis-o-amino(thio)phenols, and their preparation
07/2000
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
06/2000
06/07/2000CN1255498A Process for prepn. of growth hormone stimulating secretion agent and its intermediate
05/2000
05/31/2000EP1004583A2 Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/03/2000CN1052000C Preparation of alkylimidazolidone (meth) acrylates
10/1999
10/14/1999WO1999051590A1 Substituted indolinones as kinase inhibitors
10/07/1999DE19815020A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
09/1999
09/22/1999EP0655063B1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
09/15/1999CN1045085C Water-soluble azo compound and process for producing same
07/1999
07/27/1999CA2032355C Process for the preparation of alkyl imidazolidone (meth)acrylate
05/1999
05/26/1999EP0918050A1 Bis-o-amino(thio)phenols and their preparation
05/19/1999EP0916658A1 Assays utilizing improved chemiluminescent esters, thioesters and amides
1 2 3